Leading Manufacturer of pharmaceutical medicine biocruz, moxifloxacin dexamethasone eyedrop, pcd pharma franchise in mumbai and cefpodoxime proxetil clavulanic acid tablets from Panchkula.
Biocruz Pharmaceuticals (P.) Limited is a registered Trade Mark Company under Government of India Trade Marks Registry Rg. No. 2933603 under Trade Marks Act, 1999 in Class 3 & 35. Our Brands are also Resitered TM under TM Act 1999. With our expertise and trustworthiness, we have secured a respectable position for ourselves in this domain.
Different factors for which we have attained appreciation from clients spread all across the nation are:
Quality assured product range
Adept team of professionals
Ethical business policies
Client-centric approach
Large distribution network
Transparent dealings
Excellent transport & logistic facility
Reasonable prices
Request Callback
Yes! I am Interested
Moxifloxacin Dexamethasone Eyedrop
Get Best Quote
Approx. Price: Rs 132 / PieceGet Latest Price
Product Details:
Packaging Size
5 ml
Bottle Size
5 ml
Packaging Type
Bottle
Type Of Eyedrops
Allopathic
Usage/Application
Hospital
Brand
MOXICRUZ DX EYE DROP
Manufactured By
BIOCRUZ
Shelf Life
24 MONTHS
Country of Origin
Made in India
MOXICRUZ DX EYE DROPSMoxifloxacin 0.5 % +Dexamethasone 0.1% w/v Eye DropPACKING -5ML MRP 130.00 USE:-MOXICRUZ DX EYE DROPS Moxifloxacin + Dexamethasone is used for the treatment of bacterial infection and inflammation of the eye. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping it early may make the infection come back and harder to treat.
To retain our goodwill in client's consideration, we are engaged in rendering Allopathic Pharma Franchise In Mumbai. We are a renowned pharmaceutical firm dealing into multi-dimensional range of pharmaceutical products. We have a dedicated team of professionals with us who assists in our work in the best possible manner. We are looking for Pharma Franchise in Mumbai This service is executed by our crew of diligent personnel who have proficiency in the pharmaceutical domain.